PET plus

Plenty of topics for discussion at interzoo

I have just received my copy of the new magazine PET in Europe, which I can say is informative, well presented and deals with issues and articles at the heart of the European pet trade", a recipient at one English industrial Company has written to us. And the press officer of a large aquatics firm comments: "A great magazine. The first issue has made quite an impression on my colleagues too."

We are delighted by all the kind and encouraging letters, faxes and e-mails that have arrived at the PET in Europe editorial office following the appearance of our first issue. These prove that we are evidently on the right track with our new magazine.

We hope that the current issue is also to your liking. Once again, there's no shortage of interesting topics. Europe's largest specialist pet chain, Fressnapf, has opened a Superlative themed store in Berlin, the dominant Malenstein Group in the Netherlands has moved into its new logistics centre and in Belgium the Tom & Co. trading group has launched a new concept.

There's a lot of activity at present on the industrial front too. The EU Commission has now given the green light for the takeover of Royal Canin by Masterfoods. The Pfizer pharmaceuticals group has announced that its subsidiary Tetra is up for sale, and the aquatics firm Rena has been acquired by the Mars Group.

Topics for discussion at Interzoo have been taken care of. Over l 000 exhibitors are expected at the world's largest pet fair in Nuremberg. On the Dähne Verlag stand 2.19 in Hall 4, we can chat about current issues in our industry over a cup of coffee. We look forward to your visit.

Your

Ralf Majer-Abele

Deep insights, facts & figures: Premium information for the pet industry.
  • Retailers and suppliers: exclusive insights
  • Market analyses and country reports
  • Magazine in print and digital
  • Latest news and archive
TRIAL OFFER
Subscription
Continue reading now

Back to homepage
Related articles
petworldwide

THE CURRENT ISSUE:

THE CURRENT ISSUE:

Exclusively for subscribers

Read also